Psychiatry AtlasMedication guide · United States

Benzodiazepine for panic and selected seizure disorders

Clonazepam (Klonopin)

Generic name
clonazepam
Brand names
Klonopin
Medication class
Benzodiazepine for panic and selected seizure disorders
Forms covered
Klonopin oral tablets; Clonazepam orally disintegrating tablets

Article updated: 2026-10-30 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

Show more (3)

FDA Boxed Warning

Klonopin oral tablets; Clonazepam orally disintegrating tablets.

Combining clonazepam with opioids can cause profound sedation, slowed breathing, coma or death. Abuse, misuse and addiction can also cause overdose or death. Continued use can cause physical dependence; abrupt stopping or rapid dose reduction can cause life-threatening withdrawal, including seizures. Any reduction needs a prescriber-guided taper.

Clonazepam (Klonopin) treats panic disorder in adults and certain seizure disorders. Its benefits must be weighed against sedation, dependence and withdrawal risks.

What to expect: Calming or sedating effects can occur before a longer-term treatment plan is established.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Panic disorder with or without agoraphobia — Adults. Pediatric panic treatment is not established.Klonopin oral tablets; Clonazepam orally disintegrating tablets.
  • Specified seizure disorders — Adults and pediatric patients; specialist age/weight dosing. Lennox–Gastaut, akinetic and myoclonic seizures; selected resistant absence seizures.Klonopin oral tablets; Clonazepam orally disintegrating tablets.

What should I expect?

Calming or sedating effects can occur before a longer-term treatment plan is established. For panic disorder, follow how often attacks occur and how they affect daily life; for seizures, follow the seizure plan and record episodes.

Continued benefit and daytime alertness need reassessment. Do not treat sleepiness as proof of adequate symptom control or take extra for a difficult day without instructions.

How do I take it safely?

Take exactly as prescribed. For the reviewed dissolving tablets, use dry hands, peel back the foil and place the tablet in the mouth immediately; do not push it through the foil.

Avoid alcohol. Combining with opioids or other sedatives can dangerously slow breathing. Do not drive until the effect on alertness and coordination is clear. Store securely and never share.

Tell the clinician about breathing disease or sleep apnea, falls, depression, kidney disease, porphyria or difficulty handling saliva. Significant liver disease, acute narrow-angle glaucoma and benzodiazepine allergy are contraindications.

Review all seizure medicines and interactions. Clonazepam with valproate can cause a particular prolonged seizure state. The reviewed dissolving product contains phenylalanine, relevant to phenylketonuria; check the actual product.

Reassess benefit, breathing, mood, alertness and misuse risk. Long-term treatment may need blood counts and liver tests.

Do not abruptly stop or rapidly reduce regular use; withdrawal can cause life-threatening seizures. Use an individual taper. Take a missed dose when remembered unless the next is near; skip then and never double. Repeated missed seizure-treatment doses need prompt advice.

Late-pregnancy exposure can cause newborn sedation or withdrawal. Clonazepam enters breast milk; monitor an exposed infant for sleepiness, poor feeding or weight gain. Older adults are more sensitive to sedation, and pediatric seizure use does not establish pediatric panic treatment.

What side effects should I know about?

  • Drowsiness, dizziness, fatigue, slowed thinking and coordination difficulties.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • FDA boxed warning: combining a benzodiazepine with opioids can cause profound sedation, slowed breathing, coma and death. Benzodiazepines also carry risks of abuse, misuse and addiction. Continued use can cause physical dependence, and abrupt discontinuation or rapid dose reduction can trigger life-threatening withdrawal, including seizures.
  • Do not abruptly stop or rapidly reduce regular treatment: withdrawal can cause life-threatening seizures, including a prolonged seizure emergency.
  • New suicidal thoughts or a severe mood or behavior change needs immediate clinical contact; get emergency help if someone cannot stay safe.
  • New agitation, aggression or worsening seizure patterns needs prompt assessment.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.

What else should I know to stay safe?

  • Benzodiazepine allergy, significant liver disease and acute narrow-angle glaucoma are contraindications. Review sleep apnea or other breathing disease, kidney disease, falls, depression, porphyria and difficulty handling saliva. Some dissolving tablets contain phenylalanine, relevant to phenylketonuria.
  • Avoid alcohol and unreviewed sedatives; opioid combinations can dangerously suppress breathing. Other seizure medicines need review, including the risk of a prolonged absence-seizure state with valproate. Do not drive while impaired; store securely and never share.
  • Use an individual gradual reduction plan after regular treatment. Reassess benefit, breathing, mood and alertness; long-term use may need blood counts and liver tests. Discuss pregnancy and breastfeeding: newborn or infant sedation, withdrawal and feeding problems are possible. Older adults are more sensitive to impairment.
  • Long-term clonazepam treatment for a childhood seizure disorder needs regular benefit-and-risk review with the specialist. The label notes that possible effects on physical or mental development may become apparent only after years. This uncertainty calls for follow-up; do not stop abruptly, because withdrawal or worsening seizures can be dangerous.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Physical dependence can develop during prescribed use and is not the same as addiction. It still makes abrupt stopping unsafe.
  • A tablet that dissolves in the mouth mainly changes handling; it does not remove benzodiazepine safety risks.
  • The dose ceiling used for seizures is not a panic-disorder target. The diagnosis matters as much as the medicine name.

How does it work?

Clonazepam strengthens the effect of GABA, a chemical messenger that helps quiet nerve-cell activity. This helps explain its calming and seizure-suppressing effects, although the exact steps linking its action in the brain to these benefits are not fully understood. It is a benzodiazepine medicine.

Explore more in Brain & Science: Benzodiazepines and GABA: Alprazolam.

How was this medicine developed?

Klonopin received FDA approval in 1975. Its history includes seizure treatment and later evidence for adult panic disorder. The different indications have different doses and evidence; neither justifies borrowing the other’s regimen.

How do I say the name?

Clonazepam: kloe-NA-ze-pam. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Klonopin tablets: current prescribing information
  2. Clonazepam orally disintegrating tablets: current prescribing information
  3. Klonopin: FDA approval history
  4. Clonazepam: patient medicine information
  5. Klonopin: FDA prescribing information
  6. Klonopin: Package Insert / Prescribing Information
  7. Xanax: current alprazolam prescribing information
  8. Clonazepam: verified neutral parent, PubChem CID 2802
  9. ISMP List of Confused Drug Names
  10. Frequently Asked Questions about Labeling for Prescription Medicines | FDA

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top